All In Biotech

Free tool

FAERS Monitor: Mircera

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125164 or its brand name (Mircera, Methoxy Polyethylene Glycol-Epoetin Beta). Reports on generic versions are filed under their own applications.

Reports

11,052

Serious

7,930

72% of reports

Hospitalization

2,987

Death reported

2,926

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug hypersensitivity3,003
  • death1,583
  • dyspnoea1,139
  • nausea825
  • pruritus783
  • vomiting684
  • haemoglobin decreased587
  • flushing515
  • unresponsive to stimuli356
  • anaemia347
  • feeling hot341
  • no adverse event316
  • dizziness298
  • hypotension283
  • rash276

Reports by year received

View as table
YearReports
200844
2009137
2010192
2011245
2012778
20131,001
2014441
2015682
2016512
2017559
2018686
20191,443
2020631
2021494
2022691
2023874
2024894
2025540
2026208

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,107 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug hypersensitivitySignal3,00330.029.183,563
unresponsive to stimuliSignal35626.624.08,636
haemoglobin decreasedSignal58710.910.15,285
feeling hotSignal34110.69.62,960
flushingSignal5159.78.94,001
pruritusSignal7833.93.61,701
dyspnoeaSignal1,1393.83.62,445
deathSignal1,5833.53.32,942
anaemiaSignal3473.53.1611
no adverse eventSignal3163.33.0514
vomitingSignal6842.82.6789
hypotensionSignal2832.72.4301
nausea8252.01.9417
rash2761.21.110
dizziness2981.11.05

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.